All In Biotech

Free tool

FAERS Monitor: Doral

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018708 or its brand name (Doral, Quazepam). Reports on generic versions are filed under their own applications.

Reports

302

Serious

274

91% of reports

Hospitalization

136

Death reported

47

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • suicide attempt27
  • altered state of consciousness26
  • intentional overdose25
  • hypoglycaemia18
  • completed suicide17
  • pyrexia16
  • overdose15
  • somnolence15
  • delirium13
  • fall13
  • nausea13
  • blood creatine phosphokinase increased12
  • inappropriate antidiuretic hormone secretion12
  • toxicity to various agents12
  • insomnia11

Reports by year received

View as table
YearReports
20048
20057
200611
20075
20087
20096
20106
201118
201214
201315
201415
201541
201622
201729
201837
201910
20208
202110
202213
20237
20245
20255
20263

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,857 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
altered state of consciousnessSignal2683.757.92,042
inappropriate antidiuretic hormone secretionSignal1281.546.8874
suicide attemptSignal2731.021.6757
blood creatine phosphokinase increasedSignal1229.016.7298
intentional overdoseSignal2527.218.7606
deliriumSignal1326.115.3290
hypoglycaemiaSignal1825.916.5406
completed suicideSignal1714.29.0197
somnolenceSignal155.23.247
toxicity to various agentsSignal125.02.834
overdoseSignal154.83.042
pyrexiaSignal163.22.023
insomniaSignal112.91.612
fallSignal132.71.613
nausea131.10.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.